Phase II study of paclitaxel associated with lipid core nanoparticles (LDE) as third-line treatment of patients with epithelial ovarian carcinoma.

Published in:

2017

By:

• Graziani, Silvia;
• Vital, Carolina;
• Morikawa, Aleksandra;
• Van Eyll, Brigitte;
• Fernandes Junior, Hezio;
• Kalil Filho, Roberto;
• Maranhão, Raul;
• Graziani, Silvia R;
• Vital, Carolina G;
• Morikawa, Aleksandra T;
• Van Eyll, Brigitte M;
• Fernandes Junior, Hezio J;
• Maranhão, Raul C

Publication type:

journal article